Skip to main content
VCbacked
Log inGet Started

Reimagine Care

Nashville, United States

Reimagine Care is a health care company that provides technology-enabled services to support community-based oncology care settings.

$2.4M raised
Nov 2025
Venture - Series Unknown
Health CareHospitalMedicalOncology

Top Investors

LRVHealthSante VenturesCity of HopeOncology VenturesMartin Ventures

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Reimagine Care

How much funding has Reimagine Care raised?
Reimagine Care has raised $2.4M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in November 2025.
Who are Reimagine Care's investors?
Reimagine Care's investors include LRVHealth, Sante Ventures, City of Hope, Oncology Ventures, Martin Ventures.
Where is Reimagine Care headquartered?
Reimagine Care is headquartered in Nashville, United States.
What does Reimagine Care do?
Reimagine Care is a health care company that provides technology-enabled services to support community-based oncology care settings.
What stage is Reimagine Care at?
Reimagine Care is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Reimagine Care — Funding & Investors." VCBacked, November 19, 2025, https://www.vcbacked.co/company/reimagine-care. Accessed July 2, 2026.
APA
VCBacked. (2025). Reimagine Care — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/reimagine-care
Wikipedia (cite web)
{{cite web |title=Reimagine Care — Funding & Investors |url=https://www.vcbacked.co/company/reimagine-care |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Health Care

View all
Oryl Photonics
Lausanne
Allterum Therapeutics
Houston$1.0M
OncoRevive
Brunswick$119K
Rapport Therapeutics
Boston$250.0M
YLAH
Bern$589K
Novostia
Epalinges$6.6M